2018 Family Planning Report out now
31st December 2018
Analysis from the 2018 Family Planning Report shows a decline in the value of the public and social sector markets of the 69 FP2020 focus countries from 2011 to 2017 driven by an overall decrease in shipments of orals (combined and progestin only) and injectables. CYPs shipped declined at a similar rate over the same period driven mainly by a decrease in shipments of orals (combined and progestin only) from 2011 to 2016, and IUDs from 2016 to 2017.
The report – jointly produced by the Clinton Health Access Initiative and the Reproductive Health Supplies Coalition – shows these market trends coincide with flat and decreasing expenditures by the two largest institutional procurers of family planning products, USAID and UNFPA. Uncertainties over longer-term donor funding and growing funding gaps highlighted by the 2018 RHSC Global Contraceptive Commodity Gap Analysis remain critical factors in determining the health of this market.
Drawing on discussions with stakeholders, the report proposes explanations for the more prominent observed trends. For instance, suggested reasons for the decrease in IUD shipments from 2016 to 2017 included: the devaluation of the Egyptian Pound against the U.S. dollar leading to decreased international procurement of health products, including IUDs, in Egypt; the discontinuation of USAID’s funding support for contraceptive products in Pakistan; and cyclical procurement patterns for the remaining top markets.
A webinar on January 22, 2019 will discuss the report's findings.
The 2018 Family Planning Market Report, now in its fourth iteration, features data from 14 suppliers, all of which had also participated in the 2017 report. The report continues to provide the community with the most comprehensive and reliable view into the public and social sectors of the family planning procurement market across the 69 FP2020 focus countries.
The report is a product of the Global Markets Visibility Project. Produced with support from the Reproductive Health Supplies Coalition, it provides insightful and strategic outputs for donors, Ministries of Health (MoH), implementing organizations, and suppliers to develop and implement more effective strategies aimed at ensuring that an additional 120 million women in the world’s 69 poorest countries have access to family planning products and services by 2020. We thank the 14 participating suppliers for their important contribution in this initiative and DFID for funding this valuable project.